Henan Jinyuan Hydrogenated Chemicals (2502) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
16 Oct, 2026Executive summary
Revenue rose 33.1% to RMB3,102.0 million, but profit for the year fell to RMB11.5 million from RMB82.3 million; owners recorded a RMB16.0 million loss.
Higher refined-chemical capacity lifted sales volumes, while weaker gross margin, a refined-oil consumption-tax adjustment and higher financing costs sharply reduced earnings.
Financial highlights
Revenue was RMB3,102.0 million vs RMB2,330.2 million; gross profit was RMB71.6 million vs RMB148.8 million, and gross margin was 2.3% vs 6.4%.
Profit before tax fell to RMB12.0 million from RMB98.9 million; income tax expense was RMB0.5 million vs RMB16.6 million.
Consolidated profit was RMB11.5 million vs RMB82.3 million; attributable to owners, results shifted to a RMB16.0 million loss from RMB54.9 million profit.
Basic EPS was a loss of RMB0.02 vs earnings of RMB0.09.
Outlook and guidance
Plans include upgrading refined-chemical facilities and extending the industrial chain, improving LNG production efficiency, and expanding across hydrogen production, transport, storage, refuelling and use.
Listing proceeds for hydrogen stations and upstream/downstream investment are expected to be used during 2025–2027; implementation was delayed by market conditions.
Four hydrogen refuelling stations were operating by year-end; the two new stations opened in 2024 and recorded sales of 128.65 tonnes and 20.12 tonnes.
Latest events from Henan Jinyuan Hydrogenated Chemicals
- Capacity doubled, but margin compression cut earnings despite higher revenue.2502
H2 2023 - Revenue rose 48.9%, but input-cost pressure cut margins and H1 profit to RMB44.9m.2502
H1 2024 - Lower chemical prices compressed margins, driving an H1 net loss despite hydrogen-station growth.2502
H1 2025 - Lower chemical prices and energy margins drove a return to loss despite stronger operating cash flow.2502
H2 2025 - Improved margins restored H1 profitability despite a major receivable impairment and weaker trading sales.2502
H1 2026